GLYC-101: Phase IIb started

Glycotex began a double-blind, placebo-controlled, U.S. Phase llb trial in about 48 patients undergoing carbon dioxide laser skin resurfacing on the lower eyelid area. Novogen owns an 81% stake in Gly...